Skip to content
Scintria
ToolsGrant writerFunding
HomeLiteratureClinical trialsEvidence LabProtocol packData analysisLearnProjectsLibraryReferencesApplications
Start free
ScintriaStart free

Learn / Clinical Research Management / Close-out, transparency and professional practice

Trial and site close-out

12 minute read · 6-question quiz

Download this lesson as a colour Word or PDF study guide with the figures and answers. Included in paid plans; reading and quizzes stay free.Sign in

What you will learn

  • List the steps of site close-out and trial close-out

  • Explain final reconciliation and archiving responsibilities

  • Describe what happens to participants, samples and data after the trial

A trial is not finished when the last participant has their last visit. Close-out ensures that everything is complete, documented and ready for analysis, reporting and inspection.

Site close-out

The close-out visit (COV) happens after the last participant visit and database cleaning at the site. The CRA checks and confirms that:

  • All CRFs are complete and queries resolved.
  • All SAEs have been reported and followed up.
  • Investigational product is reconciled, and unused product returned or destroyed with documentation.
  • The Investigator Site File is complete and consistent with the TMF.
  • Biological samples are shipped, stored or destroyed as per protocol and consent.
  • Equipment loaned by the sponsor is returned, and supplies reconciled.
  • Participants' continued care is arranged, including access to the product if the protocol or ethics plan provides it.
  • Final reports to ethics committee and regulator are planned or submitted.
  • Archiving arrangements for the ISF and source documents are agreed, with the retention period and contact for access.
  • Financial reconciliation of payments to the site is complete.

Trial close-out (sponsor or CRO)

  • Database lock, unblinding and analysis.
  • All sites closed.
  • TMF reviewed for completeness and quality.
  • Final safety reconciliation.
  • Clinical study report and results registered and published.
  • Notification to regulators and ethics committees that the trial has ended.
  • Archiving of the TMF and databases.
1Last visitData entered2Clean andlockQueries closed,DB lock3Close sitesCOV, IP andfiles4Analyse andreportCSR, registry,papers5ArchiveTMF and ISFretained
From last visit to archive.

After the trial: obligations to participants and communities

  • Thank participants and tell them how the trial ended.
  • Share results in plain language, with communities and with those who took part, as agreed in the protocol or consent.
  • Continued access to an effective treatment for participants, where appropriate and agreed with the ethics committee.
  • Return of research results that matter to participants' health, according to the consent form.
  • Sample use: retain or destroy stored samples exactly as consent allows. New uses need new approval.

Retention and access

The sponsor tells sites in writing when they may destroy records. Sites keep records secure, readable and accessible for inspection, and notify the sponsor if the institution changes, the PI leaves or storage is moved.

Worked example: close-out checklist results

At a close-out visit the CRA checks 12 items.

  • 10 items are complete.
  • 1 has a minor gap: one participant's last visit CRF lacks the PI signature.
  • 1 is open: 12 vials are unaccounted for.

The CRA agrees actions with the PI: sign the CRF within 5 working days, and reconcile the vials by comparing dispensing logs and returns, with a note-to-file explaining any difference. The site is not formally closed until both are resolved and documented. Completion is 10 / 12 = 83% until then.

Leave the site better than you found it

A well-closed site is easier to inspect years later and more willing to work with the sponsor again.

Do not archive in a hurry

Closing a trial without reconciling product, safety reports or the site file creates problems that surface at inspection, when staff have moved on.

Check yourself

Write the close-out checklist for a trial you have worked on. Which item is most likely to be left open?

Summary

  • Close-out verifies complete CRFs, queries, SAEs, product, samples, site file, final reports and archiving.

  • Trial close-out includes database lock, analysis, CSR, TMF review and notifications.

  • Obligations continue to participants and communities after the trial ends.

  • Records must be kept for the required period, accessible and secure.

Check your understanding

Question 1
1

The close-out visit confirms, among other things:

Question 2
2

Stored samples after the trial should be:

Question 3
3

10 of 12 checklist items complete gives:

Question 4
4

Who tells a site when it may destroy trial records?

Question 5
5

A final report is sent to the ethics committee:

Question 6
6

Sharing results with participants and communities is:

Draft study guide. Spotted an error or something unclear? Tell us at hello@scintria.com. This is educational material, not clinical or regulatory advice.

Different kinds of studies: vaccines, devices, observational and decentralised trialsTransparency: registration, results and publication